Skip to content

The cardiac toxicity caused by anthracycline-based chemotherapy in patients with lymphoma: one observational study.

The cardiac toxicity caused by anthracycline-based chemotherapy in patients with lymphoma: one observational study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019337
Enrollment
Unknown
Registered
2018-11-06
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

Case series:none

Sponsors

Department of Hemotology, the First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. aged more than 18 years old; 2. have been diagnosed with lymphoma and are going to receive chemotherapy which formula contains anthracycline drugs.

Exclusion criteria

Exclusion criteria: 1. Have received chemotherapy before the current study. 2. Not suitable to received chemotherapy because of serious renal or liver function damage; 3. Can not tolerance the necessary radiography examination, for example be allergic to the contrast agents or pregnancy, etc.; 4. Have been diagnosed with serious cardiovascular diseases, such as cardiomyopathy, serious arrhythmia, etc.; 5. Obvious hypertension which is not easy to be controlled; 6. Other situations which are not suitable to be enrolled into the current study judged by the researcher.

Design outcomes

Primary

MeasureTime frame
TNT, TNI;BNP;LVEF;GLS;reperfusion defect area;holter monitoring;

Countries

China

Contacts

Public ContactTANG Xiaoqiong

the First Affiliated Hospital of Chongqing Medical University

tangxiaoqiong@126.com+86 13638332366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026